INPROTHER ApS is a Danish APS based in Frederiksberg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2011, the company has 22 employees and reported revenue of -12,5 mio. kr. in its latest annual filing.
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at udvikle immunterapier mod kræft, aldring og neurodegenerative sygdomme som ALS, MS og Alzheimers samt enhver anden virksomhed, som bestyrelsen anser for at være forbundet hermed.
In its most recent annual report (2025), INPROTHER ApS reported a gross profit of -12,5 mio. kr.. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 21,2 mio. kr..
